ScholarIQanswers from OpenAlex & ORCID
Hans‐Peter Helfrich
ResearcherPublications, citations & collaboration network
Hans‐Peter Helfrich is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Hans‐Peter Helfrich have?
ScholarIQindexed works
Hans‐Peter Helfrich has 25 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Hans‐Peter Helfrich have?
ScholarIQcitation count
Hans‐Peter Helfrich has 558 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Hans‐Peter Helfrich?
ScholarIQh-index
Hans‐Peter Helfrich has an h-index of 13 in OpenAlex.
What is the i10-index of Hans‐Peter Helfrich?
ScholarIQi10-index
Hans‐Peter Helfrich has an i10-index of 13 in OpenAlex.
What is the OpenAlex record for Hans‐Peter Helfrich?
ScholarIQopenalex
The OpenAlex for Hans‐Peter Helfrich is on the source record.
What are the most-cited papers on Hans‐Peter Helfrich?
ScholarIQmost cited works
Epicatechin ingested via cocoa products reduces blood pressure in humans: a nonlinear regression model with a Bayesian approach
Sabine Ellinger, Andreas Reusch, Peter Stehle, Hans‐Peter Helfrich
Kinetics of ʟ-Theanine Uptake and Metabolism in Healthy Participants Are Comparable after Ingestion of ʟ-Theanine via Capsules and Green Tea4
Lisa Scheid, Sabine Ellinger, Birgit Alteheld, Hannes Herholz, Jörg Ellinger, Thomas Henn, Hans‐Peter Helfrich, Peter Stehle
Regular Intake of a Usual Serving Size of Flavanol-Rich Cocoa Powder Does Not Affect Cardiometabolic Parameters in Stably Treated Patients with Type 2 Diabetes and Hypertension—A Double-Blinded, Randomized, Placebo-Controlled Trial
Lisa Dicks, Natalie Kirch, Dorothea Gronwald, Kerstin Wernken, Benno F. Zimmermann, Hans‐Peter Helfrich, Sabine Ellinger
A trust region algorithm for parametric curve and surface fitting
Hans‐Peter Helfrich, D. Zwick
A nutritive dose of pure (–)-epicatechin does not beneficially affect increased cardiometabolic risk factors in overweight-to-obese adults—a randomized, placebo-controlled, double-blind crossover study
Natalie Kirch, Lea Berk, Yvonne Liegl, Marcel Adelsbach, Benno F. Zimmermann, Peter Stehle, Birgit Stoffel‐Wagner, Norbert Ludwig, Andreas Schieber, Hans‐Peter Helfrich, Sabine Ellinger